title: Cutaneous sarcoidosis in a melanoma patient under Ipilimumab therapy.
authors.affiliation: Departments of Dermatology. lorenamarleb@gmail.com.
authors.forename: L
authors.initials: L
authors.lastname: Martínez Leboráns
authors.affiliation: Departments of Dermatology.
authors.forename: A
authors.initials: A
authors.lastname: Esteve Martínez
authors.affiliation: Departments of Dermatology.
authors.forename: A M
authors.initials: AM
authors.lastname: Victoria Martínez
authors.affiliation: Departments of Dermatology.
authors.forename: V
authors.initials: V
authors.lastname: Alegre de Miquel
authors.affiliation: Oncology, Valencia University General Hospital, Valencia, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Berrocal Jaime
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001706:Biopsy; D002830:Choroid Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D002990:Clobetasol / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D000074324:Ipilimumab; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology / Q000556:secondary; D008875:Middle Aged; D012507:Sarcoidosis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D012871:Skin Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D005938:Glucocorticoids; D000074324:Ipilimumab; D002990:Clobetasol